Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 18Carcinoma, Hepatocellular 11Stomach Neoplasms 10Esophageal Squamous Cell Carcinoma 10Squamous Cell Carcinoma of Head and Neck 9Lung Neoplasms 8Colorectal Neoplasms 8Rectal Neoplasms 5Advanced Solid Tumor 5Head and Neck Neoplasms 4Triple Negative Breast Neoplasms 3Esophageal Neoplasms 3Cholangiocarcinoma 3Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Neoplasm, Residual 2Nasopharyngeal Carcinoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Colonic Neoplasms 2Biliary Tract Neoplasms 2Advanced Solid Tumour 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of External Auditory Canal 1Solid Tumor, Adult 1Solid Tumor 1Small Cell Lung Cancer Extensive Stage 1Simpson-Golabi-Behmel syndrome 1Sarcoma 1Renal Pelvic Carcinoma 1

Interventions

Nivolumab 11Oxaliplatin 6Fluorouracil 6Capecitabine 5pembrolizumab 4Paclitaxel 4Leucovorin 4durvalumab 3Radiotherapy 3Folfox protocol 3Drug Therapy 3dehydroftorafur 2Trastuzumab 2Specimen Handling 2Radiation 2Metformin 2Magnetic Resonance Spectroscopy 2Itraconazole 2Irinotecan 2Docetaxel 2Cisplatin 2Carboplatin 2zolbetuximab 1zanidatamab 1trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma Of Esophagus × tislelizumab × Clear all
NCT07059299 2025-12-19

NeoTISLEGA

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 1 Recruiting
18 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡